Market Research > Industries > Chemicals

Market Research: Specialty Excipients for Oral
Solid-Dosage-Form Pharmaceuticals 2008:
U.S. Market Analysis and Opportunities

Specialty Excipients for Oral Solid-Dosage-Form Pharmaceuticals 2008: U.S. Market Analysis and Opportunities

Published August 2008

View PDF brochure

This report provides a comprehensive examination of the complex and fragmented global market for oral solid-dosage products. Each regional volume features distinct and detailed analyses of five major specialty excipient categories and more than 25 individual products. Key industry dynamics and trends are also examined in each volume. Detailed assessments of specialty excipient procurement practices and business profiles of leading and niche specialty excipient and delivery technology suppliers are provided for each region. A forecast to 2015 completes each regional volume. (Y611D)

	ORDER ONLINE

You may submit an online request to subscribe to sections of this report, using a simple three-step process. After submitting your online request, you will then be contacted by a member of our global sales team to confirm the final price, and complete the transaction. Upon acceptance of your order, we will deliver the files in pdf format via email.

STEP 1 of 3

– Select the sections in which you are interested by clicking on the appropriate boxes:

Full Report [US$ 31 250 (thirty one thousand two hundred fifty US Dollars)]

Introduction [US$ 0]

Table 1-1 SELECTED SPECIALTY EXCIPIENTS COVERED IN THIS STUDY BY PRODUCT CLASS
Table 1-2 COMMON ABBREVIATIONS AND ACRONYMS USED IN THIS REPORT

Pharmaceutical Industry Overview [US$ 3 800]

Table 3-1 NUMBER OF DISPENSED PRESCRIPTIONS IN THE UNITED STATES BY DELIVERY FORM, 2006
Table 3-2 MANUFACTURERS’ SALES OF PHARMACEUTICALS IN THE UNITED STATES BY DELIVERY FORM, 2006
The Global Market [US$ 2 100]
- Table 3-3 GLOBAL MANUFACTURERS’ SALES OF PHARMACEUTICALS BY REGION, 2007
- Table 3-4 TOP 10 PHARMACEUTICAL PRODUCTS BY GLOBAL MANUFACTURERS’ SALES, 2007
- Table 3-5 TOP 10 THERAPY CLASSES BY GLOBAL MANUFACTURERS’ SALES, 2007
- Table 3-6 HEALTHCARE REVENUES AND RESEARCH AND DEVELOPMENT EXPENDITURES FOR LEADING GLOBAL PHARMACEUTICAL/BIOTECHNOLOGY COMPANIES, 2006
- Table 3-7 RESEARCH AND DEVELOPMENT EXPENDITURES AS A PERCENTAGE OF SALES FOR PhRMA MEMBER COMPANIES, 1996 TO 2006
- Figure 3-1 RESEARCH AND DEVELOPMENT EXPENDITURES BY BIOPHARMACEUTICAL COMPANIES, 1980 TO 2006
The U.S. Market [US$ 2 100]
- Table 3-8 MANUFACTURERS’ SALES OF PRESCRIPTION DRUGS FOR THE TOP TEN PHARMACEUTICAL COMPANIES IN THE UNITED STATES, 2006
- Table 3-9 MANUFACTURERS’ SALES OF PRESCRIPTION DRUGS FOR THE TOP TEN THERAPEUTIC CLASSES IN THE UNITED STATES, 2006
- Table 3-10 MANUFACTURERS’ SALES OF THE TOP TEN PRESCRIPTION PRODUCTS IN THE UNITED STATES, 2006
- Table 3-11 MANUFACTURERS’ SALES OF NONPRESCRIPTION DRUGS IN THE UNITED STATES BY PRODUCT CLASS AND CATEGORY, 2001 TO 2006
- Figure 3-2 MANUFACTURERS’ SALES OF NONPRESCRIPTION DRUGS IN THE UNITED STATES BY PRODUCT CLASS, 2006
- Table 3-12 SALES OF TOP 25 NONPRESCRIPTION BRANDS, 2005 AND 2006
- Table 3-13 ESTIMATED MANUFACTURERS’ SALES OF NONPRESCRIPTION DRUGS IN THE UNITED STATES BY COMPANY, 2006
- Table 3-14 GROWTH IN U.S. MANUFACTURERS’ SALES OF NONPRESCRIPTION DRUGS, 2005 TO 2006
- Table 3-15 NONPRESCRIPTION DRUG SALES OF THE LEADING 14 COMPANIES IN THE UNITED STATES BY PRODUCT CLASS, 2006
- Table 3-16 SALES OF LEADING NONPRESCRIPTION DRUG COMPANIES IN THE UNITED STATES BY PRODUCT CLASS, 2006
- Table 3-17 LIST OF TOP 10 UNBRANDED GENERIC COMPANIES IN THE UNITED STATES RANKED BY SALES AND PRESCRIPTIONS DISPENSED, 2007
- Table 3-18 SALES OF THE TOP 10 GENERIC DRUGS BY PRESCRIPTIONS DISPENSED IN THE UNITED STATES, 2006 TO 2007
- Table 3-19 GROWTH OF PRIVATE-LABEL SALES AND PERCENTAGE OF TOTAL PRIVATE-LABEL SALES IN THE UNITED STATES, 2005 AND 2006
- Table 3-20 MANUFACTURERS’ SALES OF SELECTED PRIVATE-LABEL NONPRESCRIPTION DRUGS IN THE UNITED STATES AS A PERCENTAGE OF CATEGORY SALES, 2006
- Table 3-21 CHANNEL DISTRIBUTION OF DISPENSED PRESCRIPTIONS IN THE UNITED STATES, 2004 TO 2006
- Table 3-22 SELECTED MAJOR PRESCRIPTION THERAPEUTIC CLASSES, 2006
- Table 3-23 SELECTED MAJOR NONPRESCRIPTION DRUG CLASSES, 2006

Specialty Binders and Fillers [US$ 9 400]

Table 4-1 ESTIMATED CONSUMPTION OF SPECIALTY BINDERS AND FILLERS IN THE UNITED STATES BY PRODUCT CLASS AND TYPE, 2007
Table 4-2 SUPPLIERS OF SPECIALTY BINDERS AND FILLERS TO THE OSDF PHARMACEUTICAL MARKET IN THE UNITED STATES, 2007
Table 4-3 ESTIMATED VOLUME SALES OF SPECIALTY BINDERS AND FILLERS FOR OSDF PHARMACEUTICAL APPLICATIONS IN THE UNITED STATES BY SUPPLIER AND PRODUCT CLASS, 2007
Table 4-4 ESTIMATED VALUE SALES OF SPECIALTY BINDERS AND FILLERS FOR OSDF PHARMACEUTICAL APPLICATIONS IN THE UNITED STATES BY SUPPLIER AND PRODUCT CLASS, 2007
Table 4-5 FORECAST CONSUMPTION OF SPECIALTY BINDERS AND FILLERS FOR OSDF PHARMACEUTICAL APPLICATIONS IN THE UNITED STATES BY PRODUCT CLASS AND TYPE, 2007 TO 2012

Alginates [US$ 900]

Table 4A-1 ESTIMATED SALES OF ALGINATES FOR OSDF PHARMACEUTICAL APPLICATIONS IN THE UNITED STATES BY SUPPLIER, 2007

Cellulosics [US$ 3 000]

Table 4B-1 ESTIMATED SALES OF CELLULOSICS FOR OSDF PHARMACEUTICAL APPLICATIONS IN THE UNITED STATES BY PRODUCT TYPE, 2007

Table 4B-2 ESTIMATED SALES VOLUME OF CELLULOSICS FOR OSDF PHARMACEUTICAL APPLICATIONS IN THE UNITED STATES BY SUPPLIER AND PRODUCT TYPE, 2007

Table 4B-3 ESTIMATED SALES VALUE OF CELLULOSICS FOR OSDF PHARMACEUTICAL APPLICATIONS IN THE UNITED STATES BY SUPPLIER AND PRODUCT TYPE, 2007

Table 4B-4 FORECAST SALES OF CELLULOSICS FOR OSDF PHARMACEUTICAL APPLICATIONS IN THE UNITED STATES BY SUPPLIER, 2007 TO 2012
Carboxymethylcellulose sodium [US$ 900]

Table 4B-5 ESTIMATED SALES OF CMC FOR OSDF PHARMACEUTICAL APPLICATIONS IN THE UNITED STATES BY SUPPLIER, 2007

Ethyl cellulose [US$ 900]

Table 4B-6 ESTIMATED SALES OF EC FOR OSDF PHARMACEUTICAL APPLICATIONS IN THE UNITED STATES BY SUPPLIER, 2007

Hydroxypropyl cellulose [US$ 600]

Table 4B-7 ESTIMATED SALES OF HPC FOR OSDF PHARMACEUTICAL APPLICATIONS IN THE UNITED STATES BY SUPPLIER, 2007

Hydroxypropyl methylcellulose [US$ 900]

Table 4B-8 ESTIMATED SALES OF HPMC FOR OSDF PHARMACEUTICAL APPLICATIONS IN THE UNITED STATES BY SUPPLIER, 2007

Methylcellulose [US$ 900]

Table 4B-9 ESTIMATED SALES OF MC FOR OSDF PHARMACEUTICAL APPLICATIONS IN THE UNITED STATES BY SUPPLIER, 2007

Microcrystalline Cellulose [US$ 900]

Table 4B-10 ESTIMATED SALES OF MCC FOR OSDF PHARMACEUTICAL APPLICATIONS IN EUROPE BY SUPPLIER, 2007

Dicalcium Phosphate [US$ 900]

Table 4C-1 ESTIMATED SALES OF CALCIUM PHOSPHATE FOR OSDF PHARMACEUTICAL APPLICATIONS IN THE UNITED STATES BY SUPPLIER, 2007

Directly Compressible Sucrose [US$ 900]

Table 4D-1 ESTIMATED SALES OF DCS FOR OSDF PHARMACEUTICAL APPLICATIONS IN THE UNITED STATES BY SUPPLIER, 2007

Lactose [US$ 900]

Table 4E-1 ESTIMATED SALES OF LACTOSE FOR OSDF PHARMACEUTICAL APPLICATIONS IN THE UNITED STATES BY SUPPLIER, 2007

Polyols [US$ 1 600]

Table 4F-1 ESTIMATED SALES OF POLYOLS FOR OSDF PHARMACEUTICAL APPLICATIONS IN THE UNITED STATES BY SUPPLIER, 2007
Mannitol [US$ 900]

Table 4F-2 ESTIMATED SALES OF MANNITOL FOR OSDF PHARMACEUTICAL APPLICATIONS IN THE UNITED STATES BY SUPPLIER, 2007

Sorbitol [US$ 900]

Table 4F-3 ESTIMATED SALES OF SORBITOL FOR OSDF PHARMACEUTICAL APPLICATIONS IN THE UNITED STATES BY SUPPLIER, 2007

Povidone [US$ 900]

Table 4G-1 SALES OF POVIDONE FOR OSDF PHARMACEUTICAL APPLICATIONS IN THE UNITED STATES BY SUPPLIER, 2007

Starches [US$ 900]

Table 4H-1 ESTIMATED SALES OF MODIFIED STARCHES FOR OSDF PHARMACEUTICAL APPLICATIONS IN THE UNITED STATES BY SUPPLIER, 2007

Table 4H-2 ESTIMATED SALES OF UNMODIFIED STARCHES FOR OSDF PHARMACEUTICAL APPLICATIONS IN THE UNITED STATES BY SUPPLIER, 2007

Xanthan Gum [US$ 900]

Table 4I-1 ESTIMATED SALES OF XANTHAN GUM FOR OSDF PHARMACEUTICAL APPLICATIONS IN THE UNITED STATES BY SUPPLIER, 2007

Disintegrants [US$ 3 800]

Table 5-1 ESTIMATED CONSUMPTION OF DISINTEGRANTS FOR OSDF PHARMACEUTICAL APPLICATIONS IN THE UNITED STATES BY PRODUCT TYPE, 2007
Table 5-2 ESTIMATED CONSUMPTION OF DISINTEGRANTS FOR OSDF PHARMACEUTICAL APPLICATIONS IN THE UNITED STATES BY SUPPLIER, 2007
Table 5-3 FORECAST CONSUMPTION OF DISINTEGRANTS FOR OSDF PHARMACEUTICAL APPLICATIONS IN THE UNITED STATES BY PRODUCT TYPE, 2007 TO 2012

Crospovidone [US$ 1 500]

Table 5A-1 ESTIMATED SALES OF CROSPOVIDONE FOR OSDF PHARMACEUTICAL APPLICATIONS IN THE UNITED STATES BY SUPPLIER, 2007

Croscarmellose Sodium [US$ 1 500]

Table 5B-1 ESTIMATED SALES OF CCS FOR OSDF PHARMACEUTICAL APPLICATIONS IN THE UNITED STATES BY SUPPLIER, 2007

Sodium Starch Glycolate [US$ 1 500]

Table 5C-1 ESTIMATED SALES OF SSG FOR OSDF PHARMACEUTICAL APPLICATIONS IN THE UNITED STATES BY SUPPLIER, 2007

Lubricants: Magnesium stearate [US$ 3 100]

Table 6-1 ESTIMATED SALES OF MAGNESIUM STEARATE FOR OSDF PHARMACEUTICAL APPLICATIONS IN THE UNITED STATES BY SUPPLIER, 2007

Coatings [US$ 4 700]

Table 7-1 LIST OF SELECTED POLYMER FILM FORMERS USED IN COATINGS FOR OSDF APPLICATIONS, 2007
Table 7-2 LIST OF SELECTED FORMULATED COLOR COATINGS FOR OSDF APPLICATIONS, 2007
Table 7-3 ESTIMATED CONSUMPTION OF POLYMERS USED IN ODSF PHARMACEUTICAL APPLICATIONS IN THE UNITED STATES BY PRODUCT SEGMENT AND TYPE, 2007
Table 7-4 ESTIMATED SALES OF PHARMACEUTICAL AND FORMULATED COATINGS IN THE UNITED STATES BY PRODUCT SEGMENT AND COMPANY, 2007
Table 7-5 FORECAST SALES OF PHARMACEUTICAL AND FORMULATED COATINGS IN THE UNITED STATES BY PRODUCT SEGMENT AND TYPE, 2007 TO 2012

Polymers/Film Formers [US$ 3 100]

Table 7A-1 SELECTED COMMERCIAL POLYMERS FOR COATING APPLICATIONS

Table 7A-2 TABLET FUNCTIONS OF POLYMERS USED AS FILM FORMERS BY TYPE

Table 7A-3 SELECTED POLYMERS USED AS FILM FORMERS FOR OSDF PHARMACEUTICALS IN THE UNITED STATES BY PRODUCT TYPE

Table 7A-4 ESTIMATED CONSUMPTION OF POLYMERS AS FILM FORMERS FOR OSDF PHARMACEUTICAL APPLICATIONS IN THE UNITED STATES BY PRODUCT TYPE, 2007

Table 7A-5 ESTIMATED SALES OF POLYMERS AS FILM FORMERS FOR OSDF PHARMACEUTICAL APPLICATIONS IN THE UNITED STATES BY SUPPLIER, 2007
Polymethacrylates [US$ 900]

Table 7A-6 SELECTED COMMERCIAL POLYMETHACRYLATES FOR COATING APPLICATIONS

Table 7A-7 ESTIMATED SALES OF POLYMETHACRYLATES FOR OSDF PHARMACEUTICAL APPLICATIONS IN THE UNITED STATES BY SUPPLIER, 2007

Hydroxypropyl methylcellulose [US$ 900]

Table 7A-8 ESTIMATED SALES OF HPMC FOR OSDF PHARMACEUTICAL APPLICATIONS IN THE UNITED STATES BY SUPPLIER, 2007

Ethyl cellulose [US$ 900]

Table 7A-9 ESTIMATED SALES OF EC FOR OSDF PHARMACEUTICAL APPLICATIONS IN THE UNITED STATES BY SUPPLIER, 2007

Cellulose acetate phthalate [US$ 900]

Formulated Coatings [US$ 700]

Table 7B-1 LIST OF SELECTED FORMULATED COLOR COATINGS FOR OSDF APPLICATIONS, 2007
Table 7B-2 ESTIMATED SALES OF FORMULATED PHARMACEUTICAL COATINGS IN THE UNITED STATES BY SUPPLIER, 2007

Coating Types [US$ 700]

Table 7C-1 FUNCTIONALITIES OF SELECTED POLYMERS FOR OSDF COATINGS APPLICATIONS, 2007

Table 7C-2 SELECTED PRODUCTS FOR FILM COATING APPLICATIONS

Figure 7C-1 FACTORS INFLUENCING THE SUGAR-COATING PROCESS

Figure 7C-2 LAYERING COMBINATIONS FOR SUGAR-COATING APPLICATIONS

Figure 7C-3 SELECTED RAW MATERIALS FOR SUGAR COATINGS BY COATING CATEGORY

Coating Functions [US$ 900]

Aesthetic/Finishing Coatings [US$ 300]

Protective Coatings [US$ 300]

Enteric/Delayed Coatings [US$ 300]

Sustained-Release Coatings [US$ 300]

Specialty Excipients Used in Matrix Delivery Systems [US$ 3 600]

Table 8-1 LIST OF POLYMERS THAT CAN BE USED AS MATRIX FORMERS
Table 8-2 EXAMPLES OF DRUGS FORMULATED INTO A MATRIX SYSTEM FOR CONTROLLED RELEASE

Technology Trends [US$ 3 600]

Table 9-1 SELECTED CONTRACT SERVICES/FUNCTIONS WITH EXAMPLES OF OUTSOURCED SPECIALTIES, 2008

Regulatory Matters [US$ 3 100]

Table 10-1 MILESTONES IN U.S. DRUG REGULATION, 1906 TO 2007

Suppliers [US$ 7 800]

Table 11-1 ESTIMATED SALES VOLUME OF SPECIALTY BINDERS, FILLERS, AND MATRIX FORMERS, DISINTEGRANTS, AND LUBRICANTS FOR OSDF APPLICATIONS IN THE UNITED STATES BY SUPPLIER, 2007
Table 11-2 ESTIMATED SALES VALUE OF SPECIALTY BINDERS, FILLERS, AND MATRIX FORMERS, DISINTEGRANTS, AND LUBRICANTS FOR OSDF APPLICATIONS IN THE UNITED STATES BY SUPPLIER, 2007
Table 11-3 ESTIMATED SALES VALUE OF COATINGS FOR OSDF APPLICATIONS IN THE UNITED STATES BY SEGMENT AND SUPPLIER, 2007
BASF [US$ 900]
- Table 11A-1 LIST OF SELECTED BASF EXCIPIENT PRODUCTS, 2007
- Table 11A-2 BASF’S SALES OF EXCIPIENTS FOR OSDF PHARMACEUTICAL APPLICATIONS IN THE UNITED STATES BY PRODUCT TYPE, 2007
- Table 11A-3 BASF’S SALES OF EXCIPIENTS FOR OSDF PHARMACEUTICAL APPLICATIONS IN EUROPE BY PRODUCT TYPE, 2007
Colorcon [US$ 900]
- Table 11B-1 LIST OF SELECTED PHARMACEUTICAL PRODUCTS AND TRADE NAMES OF COLORCON
- Table 11B-4 FORECAST SALES OF COLORCON’S EXCIPIENTS FOR OSDF PHARMACEUTICAL APPLICATIONS IN EUROPE BY PRODUCT TYPE, 2007 TO 2012
- Table 11B-2 ESTIMATED SALES OF DCS FOR OSDF PHARMACEUTICAL APPLICATIONS IN THE UNITED STATES BY SUPPLIER, 2007
- Table 11B-3 FORECAST SALES OF COLORCON’S EXCIPIENTS FOR OSDF PHARMACEUTICAL APPLICATIONS IN THE UNITED STATES BY PRODUCT TYPE, 2007 TO 2012
Eastman Chemical Company [US$ 900]

International Specialty Products Inc. [US$ 900]
- Table 11D-1 ISP’S SALES OF EXCIPIENTS FOR OSDF PHARMACEUTICAL APPLICATIONS IN THE UNITED STATES BY PRODUCT TYPE, 2007
- Table 11D-2 ISP’S SALES OF EXCIPIENTS FOR OSDF PHARMACEUTICAL APPLICATIONS IN EUROPE BY PRODUCT TYPE, 2007
- Table 11D-3 FORECAST SALES OF FMC’S EXCIPIENTS FOR OSDF PHARMACEUTICAL APPLICATIONS IN THE UNITED STATES BY PRODUCT TYPE, 2007 TO 2012
- Table 11D-4 FORECAST SALES OF FMC’S EXCIPIENTS FOR OSDF PHARMACEUTICAL APPLICATIONS IN EUROPE BY PRODUCT TYPE, 2007 TO 2012
JRS Pharma [US$ 800]
- Table 11E-1 LEADING EXCIPIENT PRODUCTS AND TRADE NAMES MARKETED TO PHARMACEUTICAL APPLICATIONS BY JRS PHARMA, 2007
- Table 11E-2 JRS PHARMA’S SALES OF EXCIPIENTS FOR OSDF PHARMACEUTICAL APPLICATIONS IN THE UNITED STATES BY PRODUCT TYPE, 2007
- Table 11E-3 JRS PHARMA’S SALES OF EXCIPIENTS FOR OSDF PHARMACEUTICAL APPLICATIONS IN EUROPE BY PRODUCT TYPE, 2007
- Table 11E-4 FORECAST SALES OF JRS’S EXCIPIENTS FOR OSDF PHARMACEUTICAL APPLICATIONS IN THE UNITED STATES BY PRODUCT TYPE, 2007 TO 2012
- Table 11E-5 FORECAST SALES OF JRS’S EXCIPIENTS FOR OSDF PHARMACEUTICAL APPLICATIONS IN EUROPE BY PRODUCT TYPE, 2007 TO 2012
Kerry Bio-Science [US$ 900]
- Table 11F-1 ESTIMATED SALES OF LACTOSE FOR OSDF PHARMACEUTICAL APPLICATIONS IN THE UNITED STATES BY SUPPLIER, 2007
Lubrizol [US$ 900]

Mallinckrodt [US$ 900]

National Starch & Chemical Company [US$ 900]
- Table 11I-1 ESTIMATED SALES OF STARCHES FOR OSDF PHARMACEUTICAL APPLICATIONS IN EUROPE BY SUPPLIER AND PRODUCT TYPE, 2007
Roquette America [US$ 900]
- Table 11J-1 LIST OF SELECTED EXCIPIENT PRODUCTS OF ROQUETTE IN THE UNITED STATES, 2007
- Table 11J-2 ROQUETTE’S SALES OF EXCIPIENTS FOR OSDF PHARMACEUTICAL APPLICATIONS IN THE UNITED STATES BY PRODUCT TYPE, 2007
- Table 11J-3 ROQUETTE’S SALES OF EXCIPIENTS FOR OSDF PHARMACEUTICAL APPLICATIONS IN EUROPE BY PRODUCT TYPE, 2007
- Table 11J-4 ESTIMATED SALES OF POLYOLS FOR OSDF PHARMACEUTICAL APPLICATIONS IN THE UNITED STATES BY SUPPLIER, 2007
- Table 11J-5 FORECAST SALES OF ROQUETTE’S EXCIPIENTS FOR OSDF PHARMACEUTICAL APPLICATIONS IN THE UNITED STATES BY PRODUCT TYPE, 2007 TO 2012
- Table 11J-6 FORECAST SALES OF ROQUETTE’S EXCIPIENTS FOR OSDF PHARMACEUTICAL APPLICATIONS IN EUROPE BY PRODUCT TYPE, 2007 TO 2012
SPI Pharma [US$ 900]

STEP 2 of 3

– Provide your contact information:

All fields in *BOLD are required.

*Name:
*Title:
*Company/Division:
*Address 1 :
Address 2 :
*City:
*State/Province:
*Zip/Postal code:
*Country:
*Phone:
Fax:
*Email:

STEP 3 of 3

– Review and accept our subscription terms and conditions by viewing and clicking below:

*Please view our terms and conditions, and check this box to indicate your acceptance of these terms and conditions.

Thank you for your interest in subscribing to our syndicated reports. To complete this process, please click on the button below and a member of our global sales team will contact you shortly to confirm the final price and complete the transaction. Upon acceptance of your order, we will deliver the files in PDF format via email.

Market Research: Specialty Excipients for Oral Solid-Dosage-Form Pharmaceuticals 2008: U.S. Market Analysis and Opportunities

Specialty Excipients for Oral Solid-Dosage-Form Pharmaceuticals 2008: U.S. Market Analysis and Opportunities

ORDER ONLINE

STEP 1 of 3

STEP 2 of 3

STEP 3 of 3

Questions?

Market Research: Specialty Excipients for Oral
Solid-Dosage-Form Pharmaceuticals 2008:
U.S. Market Analysis and Opportunities